The stock of Bovie Medical Corporation (NYSEMKT:BVX) is a huge mover today! The stock increased 4.98% or $0.2 on November 29, hitting $4.22. About 98,289 shares traded hands. Bovie Medical Corporation (NYSEMKT:BVX) has risen 108.29% since April 26, 2016 and is uptrending. It has outperformed by 103.03% the S&P500.
The move comes after 9 months positive chart setup for the $113.00M company. It was reported on Nov, 29 by Barchart.com. We have $4.39 PT which if reached, will make NYSEMKT:BVX worth $4.52M more.
Analysts await Bovie Medical Corporation (NYSEMKT:BVX) to report earnings on March, 16. They expect $-0.01 EPS, up 80.00% or $0.04 from last year’s $-0.05 per share. After $-0.01 actual EPS reported by Bovie Medical Corporation for the previous quarter, Wall Street now forecasts 0.00% EPS growth.
According to Zacks Investment Research, “Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devices and advanced coating technologies.”
Insitutional Activity: The institutional sentiment increased to 2.44 in 2016 Q2. Its up 1.90, from 0.54 in 2016Q1. The ratio is positive, as 7 funds sold all Bovie Medical Corporation shares owned while 6 reduced positions. 2 funds bought stakes while 5 increased positions. They now own 4.70 million shares or 6.35% less from 5.02 million shares in 2016Q1.
Moreover, Blackrock Fund Advisors has 0% invested in Bovie Medical Corporation (NYSEMKT:BVX) for 72,051 shares. Blackrock Invest Management Ltd Liability Corporation, a New Jersey-based fund reported 4,801 shares. Moreover, Blackrock Institutional Trust Na has 0% invested in Bovie Medical Corporation (NYSEMKT:BVX) for 12,139 shares. Royal Bank Of Canada last reported 1,000 shares in the company. Renaissance Lc has 149,600 shares for 0% of their US portfolio. Kennedy Cap Mgmt, a Missouri-based fund reported 29,179 shares. Dimensional Fund Advisors Limited Partnership last reported 0% of its portfolio in the stock. Oppenheimer And Co last reported 10,400 shares in the company. Vsr Fincl Ser holds 0.01% or 19,250 shares in its portfolio. Geode Cap Mgmt Ltd has 0% invested in the company for 73,582 shares. Moreover, Morgan Stanley has 0% invested in Bovie Medical Corporation (NYSEMKT:BVX) for 6,700 shares. Creative Planning holds 1,475 shares or 0% of its portfolio. Salem Investment Counselors holds 0.01% or 29,771 shares in its portfolio. Blackrock Advsrs Llc owns 7,643 shares or 0% of their US portfolio. Natl Bank Of America De, a North Carolina-based fund reported 102 shares.
Insider Transactions: Since August 17, 2016, the stock had 1 buy, and 0 insider sales for $299,475 net activity. McCarthy John J. III bought $299,475 worth of stock.
More news for Bovie Medical Corporation (NYSEMKT:BVX) were recently published by: Businesswire.com, which released: “Bovie Medical to Present at 28th Annual Piper Jaffray Healthcare Conference” on November 23, 2016. Seekingalpha.com‘s article titled: “Bovie Medical Corporation’s (BVX) CEO Rob Gershon on Q3 2016 Results …” and published on October 27, 2016 is yet another important article.
BVX Company Profile
Bovie Medical Corporation (Bovie), incorporated on December 3, 1982, is an energy medical device company. The Firm is also engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. The Firm operates through three divisions: Core, OEM and J-Plasma. The Firm is engaged in developing, manufacturing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor’s offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit (ESU), a handpiece and a supply of helium gas. The Company’s medical devices are marketed through its own brands, including Bovie, Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. The Firm offers its products in three categories: electrosurgery, cauteries and other products.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.